Frailty Clinical Trial - Prospective Monitoring of Angiotensin Receptor

Status Active, not recruiting

Clinical Trial Summary

The objective of this study is to establish a near-real-time prospective monitoring program in Medicare, Optum and MarketScan Research data to evaluate the benefit of new cardiovascular disease (CVD) drugs for older adults with frailty. Prospective monitoring program seeks to find early effectiveness and safety signals of new drugs by updating the analysis at regular intervals as new Medicare data become available. This study specifically aims to emulate a prospective surveillance of the effectiveness and safety of Angiotensin Receptor Neprilysin Inhibitor(ARNI) vs. a comparator, Angiotensin II Receptor Blockers (ARBs), in older adults with Heart Failure with Reduced Ejection Fraction (HFrEF) and different frailty status. This program will be enhanced by incorporating a novel claims-based frailty index, which has been shown useful in assessing how the benefits and harms of drug therapy vary by frailty.

Clinical Trial Description

Data sources of use for this study are: Medicare Database, Optum Database, and MarketScan Research Database. All data from years 2014-2020 will be included in the study. This study follows a sequential cohort monitoring design. The monitoring analysis will include 1) retrospective analysis of available data (2015-2017) at the time of first analysis (January 2021) and 2) prospective analysis of new data (2018-2020) as they become available to the researchers. Within each database, we will emulate biannual updating of data by creating a propensity score (PS)-matched cohort of new users every 6-month interval, beginning on the first marketing of ARNI (July 7, 2015-December 31, 2015, and 6-month intervals afterwards). Each sequential cohort will be followed for development of the outcomes of interest. Outcome analysis will be performed at a pre-specified 6-month interval (prospective analysis). The surveillance will be performed by frailty status (frail vs non-frail) at the time of drug initiation. The results from each database will be pooled using fixed-effects meta-analysis (assuming low heterogeneity across the databases). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04743063
Study type	Observational
Source	Brigham and Women's Hospital
Contact
Status	Active, not recruiting
Phase
Start date	January 14, 2021
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04992286` - Detection, Evaluation and Monitoring of Frailties in the Elderly (FRAGING)	N/A
Enrolling by invitation	`NCT05009706` - Self-care in Older Frail Persons With Heart Failure Intervention	N/A
Recruiting	`NCT05529147` - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting	`NCT04444544` - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed	`NCT04140890` - Supporting Habit Formation to Attenuate Prefrailty in Elders: Pilot Study	N/A
Completed	`NCT04061785` - Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women	N/A
Recruiting	`NCT03141866` - Seated Physical Activity in Ageing	N/A
Completed	`NCT04888884` - Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting
Recruiting	`NCT04145726` - Frailty In Thoracic Surgery for Esophageal Cancer
Recruiting	`NCT04717869` - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Not yet recruiting	`NCT06022666` - PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.	N/A
Not yet recruiting	`NCT06042244` - Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis	N/A
Not yet recruiting	`NCT04514536` - Evaluation of a Health Monitoring Platform for Elderly in Home Care Context	N/A
Completed	`NCT01126723` - Effects of Tai Chi on Frailty in Elderly Adults	N/A
Completed	`NCT00183040` - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging	Phase 2
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Enrolling by invitation	`NCT05047731` - Antihypertensive Deprescribing in Long-term Care	N/A
Completed	`NCT04956705` - Vitamin D and Calcium Supplementation at Danish Nursing Homes	N/A
Recruiting	`NCT03824106` - Frailty Rehabilitation	Phase 4
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms